Skip to content

Role of lactulose for prophylaxis of hepatic encephalopathy in cirrhotic patients presenting with upper gastrointestinal bleeding

Role of lactulose for prophylaxis of hepatic encephalopathy in cirrhotic patients presenting with upper gastrointestinal bleeding

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200526003
Enrollment
Unknown
Registered
2020-05-26
Start date
2012-05-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal hemorrhage is a precipitating cause of hepatic encephalopathy in cirrhosis patients. Lactulose is frist line theraphy of hepatic encephalopathy. Can lactulose prevent hepatic encephal hepatic encephalopathy lactulose cirrhosis upper gastrointestinal bleeding prevention prophylaxis

Interventions

Lactulose oral 30 ml three times per day or hold if patient developed loose stool at least 3 time per day.,syrup oral 30 ml three times per day or hold if patient developed loose stool at least 3 time
Experimental Drug,No Intervention No treatment
Lactulose,placebo

Sponsors

None
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: cirrhotic patients presenting with upper gastrointestinal bleeding who underwent esophagograstroduodenoscopy within 24 hours after symptom presentation.

Exclusion criteria

Exclusion criteria: 1. underlying disease of neurological disease 2. presence of hepatic encephalopathy at the time of admission 3. history of lactulose usage within 6 weeks before 4. severe co-morbidity such as acute kidney injury, active cardiopulmonary disease 5. history of alcohol ingestion within 7 days before

Design outcomes

Primary

MeasureTime frame
Incidence of hepatic encephalopathy day 5 incidence of hepatic encepalopathy according to west haven criteria grade 3 or more

Secondary

MeasureTime frame
Length of hospitalization form admission to discharge days

Countries

thailand

Contacts

Public ContactAttapon Rattanasupa

Hatyai Hospital

james_medd22@yahoo.com0818923346

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026